The assessment of patients with invasive bladder cancer prior to definitive treatment to enable individual planning of the most appropriate therapy.
Improving techniques in detection and assessment of invasive bladder cancer have improved our knowledge of this disease. We are still lacking information about individual patients' responses to their cancers and the ways that we can improve this but it is to be hoped that the time will come when all patients with invasive bladder cancer will be able to receive all the useful modalities of treatment specifically chosen to meet the requirements for the control of their tumours and the needs of the patients themselves.
Newling
D W
DW
Department of Urology, Princess Royal Hospital, Hull, UK.
D014408:Biomarkers, Tumor / Q000032:analysis; D003131:Combined Modality Therapy; D006801:Humans; D010347:Patient Care Planning; D011300:Preoperative Care; D001743:Urinary Bladder / Q000601:surgery; D001749:Urinary Bladder Neoplasms / Q000628:therapy*; D014547:Urinary Diversion
D014408:Biomarkers, Tumor